INM 8-K 2026-09-18

InMed Pharmaceuticals Inc. (INM) 8-K dated 2026-09-18 — accession 0001213900-26-101492. This URL is the filing, not the INM hub.

InMed Pharmaceuticals Inc. (INM) is a drug manufacturers - specialty & generic company listed on US.

InMed Pharmaceuticals Inc. filed a 8-K on 2026-09-18. Accession 0001213900-26-101492.

Cached items: 3.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. Revenue was up 7.5% from 2024-06-30 to 2025-06-30. INM currently screens at market cap $5.2M.

Not investment advice. The INM SEC hub lists recent forms. The stock page is the research view.